CHEOF (Cochlear) Short Interest


CHEOF Cochlear Ltd CHEOF
60 GF Score
Price $75.55
GF Value $219.48
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Cochlear Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

CHEOF vs ABT, SYK, MDT: Short Interest Comparison

For the Medical Devices subindustry, Cochlear's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cochlear Short Interest vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cochlear's Short Interest distribution charts can be found below:

* The bar in red indicates where Cochlear's Short Interest falls into.


CHEOF
60GF Score
Cochlear Ltd CHEOF
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Cochlear (CHEOF) Overvalued in 2026?

Based on GuruFocus' analysis, Cochlear stock appears to be undervalued. The current stock price of $75.55 is trading 65.6% below its estimated GF Value™ of $219.48. GuruFocus considers Cochlear to be Significantly Undervalued.

Key valuation signals for CHEOF:

  • Short Interest:
  • GF Value™: $219.48 vs. price of $75.55 (65.6% below fair value)
  • GF Score™: 60/100 with 2 warning signs

No single metric tells the full story. See the CHEOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cochlear Business Description

Address 1 University Avenue, Macquarie University, Sydney, NSW, AUS, 2109
Cochlear is the leading cochlear implant device manufacturer, with around 60% global market share. Developed markets contribute 80% of group revenue, where cochlear implants are the standard of care for children with severe-to-profound hearing loss. The company also actively targets the growing cohort of seniors in developed markets. Tender-oriented emerging markets contribute the remaining 20% of group revenue. Main products include cochlear implants, bone-anchored hearing aids, and associated sound processors. In fiscal 2025, 49% of revenue came from the Americas, 34% from Europe, the Middle East, and Africa, and 18% from the Asia-Pacific segment.
60GF Score

Get the complete analysis for CHEOF

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$75.55
Price
$219.48
GF Value